Cancer

For good and ill, immune response to cancer cuts both ways

The difference between an immune response that kills cancer cells and one that conversely stimulates tumor growth can be as narrow as a "double-edged sword," report researchers at the University of California, San Diego School ...

Apr 07, 2014
popularity not rated yet | comments 0

AACR: LY2835219 promising for metastatic breast cancer

(HealthDay)—The novel cell cycle inhibitor selective for the cyclin-dependent kinases CDK4 and CDK6 (CDK4/6), LY2835219, shows promise for metastatic breast cancer, according to a study presented at the ...

Apr 07, 2014
popularity not rated yet | comments 0